Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$367,791
-$91,718 QoQ
Shares Held
44,259
+2.1% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 198 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. ARVN ranks #146 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in ARVN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $367,791 | 44,259 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $459,509 | 43,350 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $717,837 | 60,526 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $441,386 | 51,806 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $381,290 | 51,806 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $374,776 | 53,387 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,027,702 | 53,610 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,418,662 | 57,599 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $1,585,113 | 59,546 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,381,360 | 57,688 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,923,241 | 46,726 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $922,038 | 46,947 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,140,353 | 45,945 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,276,498 | 46,724 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,409,895 | 41,213 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,854,921 | 41,693 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,683,641 | 40,001 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $2,547,910 | 37,859 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,035,976 | 36,961 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,821,402 | 34,332 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,083,158 | 27,054 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,503,245 | 22,742 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $452,591 | 5,329 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||